|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
HIV |
|
����3 |
| ��������������� | |
|
�Ž� |
|
κǿ |
| PubMed | |
|
Article by |
|
Article by |
����C3�ڰ��̲����������еĸ�������
�Ž�, κǿ
�Ĵ���ѧ����ҽԺ������� �ɶ� 610041
����ϵͳ����������ϵͳ����Ҫ��ɲ���,���в���C3�Dz���ϵͳ�Ĺؼ��ɷ֡�����C3����������ɷ������������ԭ���Ⱦ�Ϸ�������Ҫ���á����о���ʾ����C3����û�ж�HIV����Ӧ�е��ܽ�����,����ͨ���������ôٽ���HIV��Ⱦ����������������C3�ڴٽ�HIV��Ⱦ���Ʒ�����о���չ,������һЩ�������о�ǰ;��HIV����˼·��
[2] Susal C,Kirschfink M,Kropelin M,et al.Complement activation by recombinant HIV-1 glycoprotein gpl20.J Immunol,1994,152(12):6028-6034.
[3] Smith PD,Meng G,Sellers MT,et al.Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages.J Leukoc Biol,2000,68(3):360-365.
[4] Frank I,Kacani L,Stoiber H,et al.Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious.J Virol,1999,73(4):3449-3454.
[5] Stoitzner P,Zanella M,Ortner U,et al.Migration of langerhans cells and dermal dendritic cells in skin organ cultures:augmentation by TNF-alpha and IL-lbeta.J Leukoc Biol,1999,66(3):462-470.
[6] Kacani L,Banki Z,Zwirner J,et al.CSa and C5a(desArg)enhance the susceptibility of monocyte-derived macrophages to HIV infection.J Immunol,2001,166(5):3410-3415.
[7] Bajtay Z,Kacani L,Erdei A,et al.HIV-1 induces human monocyte-derived macrophages to produce C3 and to fix C3 on their surface.J Leukoc Biol,1998,63(4):463-468.
[8] Tacnet-Delorme P,Boyer V,Thielens NM,et al.In vitro analysis of complement-dependent HIV-1 cell infection using a model system.J Immunol,1999,162(7):4088-4093.
[9] Doepper S,Stoiber H,Kacani L,et al.B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1:role of complement.Immunobiology,2000,202(3):293-305.
[10] Moir S,Malaspina A,Li Y,et al.B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.J Exp Med,2000,192(5):637-646.
[11] Haase AT,Henry K,Zupancic M,et al.Quantitative image analysis of HIV-1 infection in lymphoid tissue.Science,1996,274(5289):985-989.
[12] Hufert FT,van Lunzen J,Janossy G,et al.Germinal centre CD4+T cells are an important site of HIV replication in vivo.AIDS,1997,11(7):849-857.
[13] Burton GF,Masuda A,Heath SL,et al.Follicular dendritic cells(FDC)in retroviral infection:host/pathogen perspectives.Immunol Rev,1997,156:185-197.
[14] Kacani L,Prodinger WM,Sprinzl GM,et al.Detachment of human immunodeficiency virus type I from germinal centers by blocking complement receptor type 2.J Virol,2000,74(17):7997-8002.
[15] Jakuhik JJ,Saifuddin M,Takefman DM,et al.B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.Immunology,1999,96(4):612-619.
[16] Pinter C,Beltrami S,Stoiber H,et al.Interference with complement regulatory molecules as a possible therapeutic strategy in HIV infection.Expert Opin Investig Drugs,2000,9(2):199-205.
[17] Jongen PJ,Doesburg WH,Ibrahim-Stappers JL,et al.Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.Acta Neurol Scand,2000,101(2):116-121.
[18] Speth C,Schabetsberger T,Mohsenipour I,et al.Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.J Virol,2002,76(7):3179-3188.
[19] Alonso CM,Lozada CJ.Effects of IV cyclophosphamide on HIV viral replication in a patient with systemic lupus erythematosus.Clin Exp Rheumatol,2000,18(4):510-512.
[20] Hlavacek WS,Wofsy C,Perelson AS.Dissociation of HIV-1 from follicular dendritic cells during HAART:mathematical analysis.Proc Natl Acad Sci U S A,1999,96(26):14681-14686.
[21] Stoiber H,Frank I,Spruth M,et al.Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type3(CR3):an accessory role for CR3 during virus entry? Mol Immunol,1997,34(12-13):855-863.